[
  {
    "ts": "2026-02-10T00:26:43+00:00",
    "headline": "Provident Dumps 490,000 MapleBear Shares Worth $18 Million",
    "summary": "Maplebear Inc. connects North American households with personal shoppers through its technology-driven grocery delivery platform.",
    "url": "https://www.fool.com/coverage/filings/2026/02/09/provident-dumps-490000-cart-shares-worth-18-million/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "23acb35f-1e9c-3173-95a4-9b49a14123f0",
      "content": {
        "id": "23acb35f-1e9c-3173-95a4-9b49a14123f0",
        "contentType": "STORY",
        "title": "Provident Dumps 490,000 MapleBear Shares Worth $18 Million",
        "description": "",
        "summary": "Maplebear Inc. connects North American households with personal shoppers through its technology-driven grocery delivery platform.",
        "pubDate": "2026-02-10T00:26:43Z",
        "displayTime": "2026-02-10T00:26:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/fc4e7308bab84ca64d2d9b8ed6703ee0",
          "originalWidth": 384,
          "originalHeight": 384,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/e09iYXfg207s9Tq26Z8Zuw--~B/aD0zODQ7dz0zODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/fc4e7308bab84ca64d2d9b8ed6703ee0.cf.webp",
              "width": 384,
              "height": 384,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kw40AFrYJ3HgenDdq8_ZVw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/fc4e7308bab84ca64d2d9b8ed6703ee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/coverage/filings/2026/02/09/provident-dumps-490000-cart-shares-worth-18-million/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/provident-dumps-490-000-maplebear-002643884.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CART"
            },
            {
              "symbol": "V"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "BKNG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T06:06:53+00:00",
    "headline": "A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Momentum",
    "summary": "Event context and recent share performance Vertex Pharmaceuticals (VRTX) has recently drawn investor attention without a single clear news catalyst, as the stock shows a month return of about 1.5% and a past 3 months return near 9.7%. See our latest analysis for Vertex Pharmaceuticals. At a share price of US$470.87, Vertex’s recent 90 day share price return of 9.7% sits alongside a relatively flat 1 year total shareholder return of 0.19%. This hints that momentum has picked up more recently...",
    "url": "https://finance.yahoo.com/news/look-vertex-pharmaceuticals-vrtx-valuation-060653761.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "a38abca9-7b14-3872-b136-d5de20a17719",
      "content": {
        "id": "a38abca9-7b14-3872-b136-d5de20a17719",
        "contentType": "STORY",
        "title": "A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Momentum",
        "description": "",
        "summary": "Event context and recent share performance Vertex Pharmaceuticals (VRTX) has recently drawn investor attention without a single clear news catalyst, as the stock shows a month return of about 1.5% and a past 3 months return near 9.7%. See our latest analysis for Vertex Pharmaceuticals. At a share price of US$470.87, Vertex’s recent 90 day share price return of 9.7% sits alongside a relatively flat 1 year total shareholder return of 0.19%. This hints that momentum has picked up more recently...",
        "pubDate": "2026-02-10T06:06:53Z",
        "displayTime": "2026-02-10T06:06:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ihFoSuY9PLXURl2kI_sV.w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bIz6sh0rX4c7ACsVP8z51w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/look-vertex-pharmaceuticals-vrtx-valuation-060653761.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/look-vertex-pharmaceuticals-vrtx-valuation-060653761.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]